Gonadotrophin-releasing hormone antagonist regimen versus agonist regimen among normal ovarian responders: a systematic review and meta-analysis

Read full text Summarise with VIRAT
Authors: Jiajie Lai, Jing LU, Xiuling Wu, Xuemei Chen, Rongju Liu
Cited by: 0
References: 25

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This systematic review and meta-analysis compared the efficacy and safety of gonadotrophin-releasing hormone antagonist (GnRH-ant) versus GnRH agonist (GnRH-a) regimens in women with a normal ovarian response undergoing controlled ovarian stimulation. PubMed, Embase, Cochrane Library, CNKI, VIP, and Wanfang were searched from inception to April 30, 2024. Randomized controlled trials were independently screened, appraised for risk of bias, and synthesized using meta-analysis. Eight RCTs involving 1,841 participants were included. Compared with GnRH-a, GnRH-ant was associated with fewer retrieved oocytes (WMD -0.77, 95% CI -1.35 to -0.20; P=0.009) and a lower implantation rate (RR 0.75, 95% CI 0.60 to 0.93; P=0.009), but required less total gonadotrophin (WMD -389.65; P

Fields of Study & Subjects

Reproductive Biology and Fertility Ovarian function and disorders Reproductive Health and Technologies

Publication details

Journal / source
African Journal of Reproductive Health
Volume
30
Issue
6
Pages
125–139
Publication date
31 March 2026
Language
EN